EP1959931A4 - Zusammensetzungen und verfahren zur dermalen schmerzbehandlung - Google Patents

Zusammensetzungen und verfahren zur dermalen schmerzbehandlung

Info

Publication number
EP1959931A4
EP1959931A4 EP06848632A EP06848632A EP1959931A4 EP 1959931 A4 EP1959931 A4 EP 1959931A4 EP 06848632 A EP06848632 A EP 06848632A EP 06848632 A EP06848632 A EP 06848632A EP 1959931 A4 EP1959931 A4 EP 1959931A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
treating pain
dermally treating
dermally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06848632A
Other languages
English (en)
French (fr)
Other versions
EP1959931A2 (de
Inventor
Jie Zhang
Kevin S Warner
Sanjay Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZARS Pharma Inc
Original Assignee
ZARS Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZARS Pharma Inc filed Critical ZARS Pharma Inc
Publication of EP1959931A2 publication Critical patent/EP1959931A2/de
Publication of EP1959931A4 publication Critical patent/EP1959931A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP06848632A 2005-12-14 2006-12-14 Zusammensetzungen und verfahren zur dermalen schmerzbehandlung Withdrawn EP1959931A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75068305P 2005-12-14 2005-12-14
US75051905P 2005-12-14 2005-12-14
US75063705P 2005-12-14 2005-12-14
PCT/US2006/047926 WO2007070679A2 (en) 2005-12-14 2006-12-14 Compositions and methods for dermally treating pain

Publications (2)

Publication Number Publication Date
EP1959931A2 EP1959931A2 (de) 2008-08-27
EP1959931A4 true EP1959931A4 (de) 2012-08-22

Family

ID=38163542

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06848632A Withdrawn EP1959931A4 (de) 2005-12-14 2006-12-14 Zusammensetzungen und verfahren zur dermalen schmerzbehandlung

Country Status (5)

Country Link
EP (1) EP1959931A4 (de)
JP (1) JP2009524586A (de)
AU (1) AU2006326018B2 (de)
CA (1) CA2633515C (de)
WO (1) WO2007070679A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
WO2008089242A1 (en) 2007-01-16 2008-07-24 Dermworx, Incorporated Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
ES2842289T3 (es) 2008-02-29 2021-07-13 Vm Therapeutics Llc Compuestos para tratar el síndrome del dolor y otros trastornos
CA2730787A1 (en) * 2008-07-16 2010-01-21 David M. Cohen Topical drug delivery system
US9012477B2 (en) 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
WO2010114973A1 (en) * 2009-04-01 2010-10-07 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
MX2011011698A (es) 2009-05-04 2012-02-29 Zars Pharma Inc Metodo para tratar dolores asociados con neuroma, entrapamiento nervioso y otras condiciones.
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
CN102834096A (zh) 2010-01-14 2012-12-19 卢福研究公司 用于疼痛控制的固态成型局部麻醉制剂
EP2672956A1 (de) 2011-02-10 2013-12-18 Moberg Pharma AB Neue formulierungen für die dermale, transdermale und mukosale verwendung 1
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
BR112013028802B1 (pt) 2011-05-10 2021-10-26 Itochu Chemical Frontier Corporation Curativo adesivo não-aquoso
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
JP2014515365A (ja) * 2011-05-26 2014-06-30 ノバルティス アーゲー 生理学的活性剤の経皮投与のための組成物
CN102302418B (zh) * 2011-09-21 2013-01-23 韩褆 节水型多功能洗手消毒液
DK2823815T3 (en) 2011-09-27 2018-08-06 Itochu Chemical Frontier Corp NON-DIFFICULT PLASTER
CN103142458B (zh) 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
GB201317718D0 (en) * 2013-10-07 2013-11-20 Buzzz Pharmaceuticals Ltd Novel formulation
JP6209749B2 (ja) * 2015-12-10 2017-10-11 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
US11141387B2 (en) 2017-01-05 2021-10-12 Medrx Co., Ltd. Memantine-containing transdermally absorbable liquid
CA3082286A1 (en) 2017-12-04 2019-06-13 Johnson & Johnson Consumer Inc. Topical emulsion composition containing nonsteroidal anti-inflammatory drug
US20240315996A1 (en) * 2021-02-02 2024-09-26 DuPont Nutrition USA, Inc. An aqueous gel composition comprising an ethylcellulose

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029735A1 (en) * 1996-02-19 1997-08-21 Monash University Dermal penetration enhancers and drug delivery systems involving same
WO2001022907A1 (en) * 1999-09-28 2001-04-05 Zars Drug delivery of phase changing formulation
WO2001037890A1 (en) * 1999-11-23 2001-05-31 Ever Power Holding Inc A propellant free spray-on skin patch composition for improving wound healing and for drug administration
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029735A1 (en) * 1996-02-19 1997-08-21 Monash University Dermal penetration enhancers and drug delivery systems involving same
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
WO2001022907A1 (en) * 1999-09-28 2001-04-05 Zars Drug delivery of phase changing formulation
WO2001037890A1 (en) * 1999-11-23 2001-05-31 Ever Power Holding Inc A propellant free spray-on skin patch composition for improving wound healing and for drug administration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KONDO S ET AL: "Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier", JOURNAL OF PHARMACOBIO-DYNAMICS, TOKYO, JP, vol. 10, 1 January 1987 (1987-01-01), pages 587 - 594, XP002611468, ISSN: 0386-846X *

Also Published As

Publication number Publication date
AU2006326018A1 (en) 2007-06-21
JP2009524586A (ja) 2009-07-02
EP1959931A2 (de) 2008-08-27
CA2633515C (en) 2011-10-18
WO2007070679A2 (en) 2007-06-21
CA2633515A1 (en) 2007-06-21
AU2006326018B2 (en) 2013-04-18
WO2007070679A3 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
IL186963A0 (en) Methods and compositions for treating pain
GB2423928B (en) Methods and compositions for treating pain
EP1959931A4 (de) Zusammensetzungen und verfahren zur dermalen schmerzbehandlung
EP1959929A4 (de) Zusammensetzungen und verfahren zur behandlung dermatologischer leiden
EP1737482A4 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten
IL186973A0 (en) Compositions and methods for treatment for neoplasms
IL187238A0 (en) Compositions and methods for treating hyperproliferative epidermal diseases
IL185540A0 (en) Compositions and methods for treating acne
IL184047A0 (en) Methods and compositions for treating amyloid-related diseases
PT3006040T (pt) Métodos e composições para o tratamento de neuropatias
IL176259A0 (en) Compositions and methods for treating diabetes
IL229039A0 (en) Solid preparations and methods for treating insomnia in the middle of the night
IL230935A0 (en) Formulations and methods for treating amyloidosis
IL191237A0 (en) Compositions and methods for treating thrombocytopenia
EP1890712A4 (de) Zusammensetzungen und verfahren zur behandlung von schmerzen
IL176919A0 (en) Methods and compositions for treating cancer
IL187405A0 (en) Methods and compositions for the treatment of pain
ZA200608932B (en) Method and compositions for epilation
IL187531A0 (en) Method and composition for treating osteoarthritis
EP1855662A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs
ZA200710205B (en) Solid compositions and methods for treating middle-of-the night insomnia
GB0504657D0 (en) Compositions and methods of treatment
GB0519334D0 (en) Method and composition for treating skin
ZA200710476B (en) Methods and compositions for the treatment of pain
GB0505203D0 (en) Skin composition treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080625

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ZARS PHARMA, INC.

R17D Deferred search report published (corrected)

Effective date: 20090108

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 37/12 20060101AFI20090120BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120725

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/74 20060101ALI20120719BHEP

Ipc: A61K 9/12 20060101AFI20120719BHEP

17Q First examination report despatched

Effective date: 20140604

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160701